Full-Service Clinical Trials in Central and Eastern Europe

Headquartered in St-Petersburg, Russia, OCT is a full-service contract research organization (CRO) providing high-quality services in clinical trials conduct in Central and Eastern Europe (CEE).
Since 2005 OCT have opened several branch offices in CEE and grown to its current size of 85 people. Our qualified clinical team includes medical doctors and R&D professionals in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic.
OCT have extensive experience in a wide range of therapeutic areas handling both drug and device trials.
We are dedicated to provide high quality yet personal service.

 

OCT Successfully Passes Big Pharma Audit

 

OCT met an interim enrollment milestone in a phase II study.

 

Multi-National Pregnancy Exposure Registry in Multiple Sclerosis (MS)

 

OCT is launching a phase I/II study in patients with myelosuppression

 

A new Phase IIA/III Study in Anemia in Chronic Kidney Disease (CKD)

 

OCT-Clinical trials in Central and Eastern Europe have completed a pilot clinical study at three sites in 60 patients

 

OCT has been awarded with a phase I/II study in oncology

 

Rescue Study in Cardiology

 

OCT has received study approval from the Russian Ministry of Health to conduct a pediatric study in infants

 

Investigators Meeting in Florence

 

OCT has been awarded with 6 local studies for a global pharmaceutical company.

 

OCT has obtained an approval for a phase I/II study to be held in two Russian centers in 35 metastatic breast cancer patients

 

OCT is happy to welcome 3 new employees at OCT

 

New Project Manager at OCT Moscow office

 

OCT Clinical Trials in CEE has made an effort to support local environmentalists to save natural resources

 

OCT is starting-up data management services for a Phase IV trial in hemispheric ischemic stroke

 

OCT is launching a Phase 2b study in bladder cancer. OCT is responsible for 3 sites in Russia

 

30th Annual J.P. Morgan Healthcare Conference, San Francisco, USA

 

21-st Annual Partnerships in Clinical Trials - Orlando, FL, U.S.

 

Biotech Showcase™ 2012

 

10-th annual Partnerships in Clinical Trials

 

The 4-th Ukrainian Pharmaceutical Forum

 

BIO Europe-2011

 

The 2-nd International Forum Innovative Drug Research and Development in Russia

“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.